Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:1055-1059
Published online before print April 5, 2004, doi: 10.1161/01.hyp.0000126110.46402.dd
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
43/5/1055    most recent
01.hyp.0000126110.46402.ddv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, J.
Right arrow Articles by Jankowski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, J.
Right arrow Articles by Jankowski, J.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Other heart failure
Right arrow Cell biology/structural biology
Right arrow Heart failure - basic studies
Right arrow Hypertension - basic studies

(Hypertension. 2004;43:1055.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Endogenous Diadenosine Tetraphosphate, Diadenosine Pentaphosphate, and Diadenosine Hexaphosphate in Human Myocardial Tissue

Jiankai Luo; Vera Jankowski; Nihayrt Güngär; Joachim Neumann; Wilhelm Schmitz; Walter Zidek; Hartmut Schlüter; Joachim Jankowski

From Medizinische Klinik IV (J.L., V.J., N.G., W.Z., H.S., J.J.), Charite-Campus Benjamin Franklin, Berlin, Germany, and Institut für Pharmakologie und Toxikologie (J.N., W.S.), Universität Münster, Germany. J.L. is currently at the Institute für Anatomie, Klinikum der Friedrich Schiller Universität Jena, Germany.

Correspondence to Dr J. Jankowski, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany. E-mail Joachim.Jankowski{at}charite.de

Diadenosine polyphosphates have been characterized as extracellular mediators controlling numerous physiological effects. In this study, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate were isolated and identified in human myocardial tissue. Human myocardial tissue was homogenized and fractionated by affinity chromatography, displacement chromatography, anion-exchange chromatography, and reversed-phase chromatography. In fractions purified to homogeneity, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate were revealed by matrix-assisted laser desorption/ionization mass spectrometry and ultraviolet spectroscopy. These diadenosine polyphosphates were further identified by enzymatic analysis, which demonstrated an interconnection of the phosphate groups with the adenosines in the 5' positions of the riboses. Furthermore, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate were found in human cardiac-specific granules, and the amount of diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate was estimated in the range of {approx}500 µmol/L. In conclusion, the experiments show that the diadenosine polyphosphates with 2 and 3 phosphate groups occur in human myocardial tissue, and so do the diadenosine polyphosphates with 4 to 6 phosphate groups. After being released by cholinergic stimulation, which is known to affect diadenosine polyphosphate release from secretory granules, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate activate P2X purinoceptors in vascular smooth muscle; hence, they can act as vasoconstrictors. It may be inferred that the differential action of both predominantly vasodilator and vasoconstrictor diadenosine polyphosphates allow a fine-tuning of myocardial blood flow by locally released diadenosine polyphosphates.


Key Words: myocardium • cardiac function